U.S. Automated And Closed Cell Therapy Processing Systems Market (2025 - 2030) Size, Share & Trends Analysis Report By Workflow (Separation, Expansion), By Type (Stem Cell Therapy, Non-stem Cell Therapy), By Scale, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation and Scope
                   1.2. Market Definitions
                       1.2.1. Workflow Segment
                       1.2.2. Type Segment
                       1.2.3. Scale Segment
                   1.3. Information analysis
                   1.4. Market formulation & data visualization
                   1.5. Data validation & publishing
                   1.6. Information Procurement
                       1.6.1. Primary Research
                   1.7. Information or Data Analysis
                   1.8. Market Formulation & Validation
                   1.9. Market Model
                   1.10. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Snapshot
                   2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent Market Outlook
                       3.1.2. Related/Ancillary Market Outlook
                   3.2. Market Dynamics
                       3.2.1. Market Driver Analysis
                           3.2.1.1. Growing emphasis on regenerative medicines and cell therapies
                           3.2.1.2. Operational superiority of automated systems over manual processing
                           3.2.1.3. Extensively increasing technological advancements
                       3.2.2. Market Restraint Analysis
                           3.2.2.1. Complications associated with cell processing systems
                   3.3. Industry Analysis Tools
                       3.3.1. Porter's Five Forces Analysis
                       3.3.2. PESTEL Analysis
                       3.3.3. COVID-19 Impact Analysis
Chapter 4. U.S. Automated and Closed Cell Therapy Processing Systems Market: Workflow Business Analysis
                   4.1. Workflow Segment Dashboard
                   4.2. U.S. Automated and Closed Cell Therapy Processing Systems Market Workflow Movement Analysis
                   4.3. U.S. Automated and Closed Cell Therapy Processing Systems Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
                   4.4. Separation
                       4.4.1. Separation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                   4.5. Expansion
                       4.5.1. Expansion Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                   4.6. Apheresis
                       4.6.1. Apheresis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                   4.7. Fill-finish
                       4.7.1. Fill-finish Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                   4.8. Cryopreservation
                       4.8.1. Cryopreservation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                   4.9. Others
                       4.9.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. U.S. Automated and Closed Cell Therapy Processing Systems Market: Type Business Analysis
                   5.1. Type Segment Dashboard
                   5.2. U.S. Automated and Closed Cell Therapy Processing Systems Market Type, Movement Analysis
                   5.3. U.S. Automated and Closed Cell Therapy Processing Systems Market Size & Trend Analysis by Type, 2018 to 2030 (USD Million)
                   5.4. Stem Cell Therapy
                       5.4.1. Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                   5.5. Non-stem Cell Therapy
                       5.5.1. Non-stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. U.S. Automated and Closed Cell Therapy Processing Systems Market: Scale Business Analysis
                   6.1. Scale Segment Dashboard
                   6.2. U.S. Automated and Closed Cell Therapy Processing Systems Market Scale Movement Analysis
                   6.3. U.S. Automated and Closed Cell Therapy Processing Systems Market Size & Trend Analysis, by Scale, 2018 to 2030 (USD Million)
                   6.4. Pre-commercial/ R&D Scale
                       6.4.1. Pre-commercial/ R&D Scale Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                   6.5. Commercial Scale
                       6.5.1. Commercial Scale Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
                   7.1. Participant Categorization
                   7.2. Strategy Mapping
                   7.3. Company Market Position Analysis, 2024
                   7.4. Participant’s Overview
                       7.4.1. Thermo Fisher Scientific Inc.
                           7.4.1.1. Overview
                           7.4.1.2. Financial Performance
                           7.4.1.3. Product Benchmarking
                           7.4.1.4. Strategic Initiatives
                       7.4.2. Lonza
                           7.4.2.1. Overview
                           7.4.2.2. Financial Performance
                           7.4.2.3. Product Benchmarking
                           7.4.2.4. Strategic Initiatives
                       7.4.3. MiltenyiBiotec
                           7.4.3.1. Overview
                           7.4.3.2. Product Benchmarking
                           7.4.3.3. Strategic Initiatives
                       7.4.4. Danaher
                           7.4.4.1. Overview
                           7.4.4.2. Financial Performance
                           7.4.4.3. Product Benchmarking
                           7.4.4.4. Strategic Initiatives
                       7.4.5. Sartorius AG
                           7.4.5.1. Overview
                           7.4.5.2. Financial Performance
                           7.4.5.3. Product Benchmarking
                           7.4.5.4. Strategic Initiatives
                       7.4.6. Fresenus
                           7.4.6.1. Overview
                           7.4.6.2. Financial Performance
                           7.4.6.3. Product Benchmarking
                           7.4.6.4. Strategic Initiatives
                       7.4.7. MaxCyte, Inc.
                           7.4.7.1. Overview
                           7.4.7.2. Product Benchmarking
                           7.4.7.3. Strategic Initiatives
                       7.4.8. ThermoGenesis Holdings, Inc.
                           7.4.8.1. Overview
                           7.4.8.2. Product Benchmarking
                           7.4.8.3. Strategic Initiatives
                       7.4.9. Terumo Corporation
                           7.4.9.1. Overview
                           7.4.9.2. Financial Performance
                           7.4.9.3. Product Benchmarking
                           7.4.9.4. Strategic Initiatives
                       7.4.10. Cellares Inc.
                           7.4.10.1. Overview
                           7.4.10.2. Product Benchmarking
                           7.4.10.3. Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S. Automated and Closed Cell Therapy Processing Systems market, by workflow, 2018 - 2030 (USD million)
Table 4 U.S. Automated and Closed Cell Therapy Processing Systems market, by type, 2018 - 2030 (USD million)
Table 5 U.S. Automated and Closed Cell Therapy Processing Systems market, by Scale, 2018 - 2030 (USD million)
Table 6 U.S. Automated and Closed Cell Therapy Processing Systems market, by region, 2018 - 2030 (USD million)
Table 7 Participant's overview
Table 8 Financial performance

List of Figures

Fig. 1 U.S. Automated and Closed Cell Therapy Processing Systems Market Segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market formulation & validation
Fig. 7 Market outlook
Fig. 8 Segment snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 Parent market outlook
Fig. 11 U.S. Automated and Closed Cell Therapy Processing Systems Market Driver Analysis
Fig. 12 U.S. Automated and Closed Cell Therapy Processing Systems Market Restraint Analysis
Fig. 13 Porter's analysis
Fig. 14 PESTEL analysis
Fig. 15 U.S. Automated and Closed Cell Therapy Processing Systems market: Workflow outlook and key takeaways
Fig. 16 U.S. Automated and Closed Cell Therapy Processing Systems market: Workflow market share analysis, 2023 - 2030
Fig. 17 Separation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Expansion market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Apheresis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Fill-finish flasks market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Cryopreservation permeable membrane flasks market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 U.S. Automated and Closed Cell Therapy Processing Systems market: Type outlook and key takeaways
Fig. 24 U.S. Automated and Closed Cell Therapy Processing Systems market: Type market share analysis, 2023 - 2030
Fig. 25 Stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Non-stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 U.S. Automated and Closed Cell Therapy Processing Systems market: Scale outlook and key takeaways
Fig. 28 U.S. Automated and Closed Cell Therapy Processing Systems market: Scale market share analysis, 2024 - 2030
Fig. 29 Pre-commercial/ R&D scale market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Commerical scale market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Key company categorization
Fig. 32 Company market positioning
Fig. 33 Market participant categorization
Fig. 34 Strategy framework